等待開盤 01-29 09:30:00 美东时间
-0.280
-0.56%
今日重点评级关注:Oppenheimer:维持Pelthos Therapeutics"跑赢大市"评级,目标价从57美元升至60美元;Small Cap Consumer Research:维持Lands' End"买入"评级,目标价从20美元升至45美元
01-27 10:02
Susquehanna analyst Bascome Majors maintains Greenbrier Companies (NYSE:GBX) with a Positive and raises the price target from $52 to $60.
01-27 00:53
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Greenbrier业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **第一季度核心财务指标:** - **营收**:7.06亿美元,基本符合预期 - **毛利率**:15%,受前一季度较低生产率和交付量影响,但租赁业务表现强劲 - **营业收入**:6,100万美元,约占营收的9% - **稀释每股收益**:1.14美元,部分得益于车队资产出售的机会性收益 - **EBITDA**:9,800万美元,相当于营收的14% - **经营现金流**:7,600万美元,得益于收益和营运资本效率提升 ## 2. 财务指标变化 **关键财务指标
01-16 12:23
LAKE OSWEGO, Ore., Jan. 13, 2026 /PRNewswire/ -- The Greenbrier Companies (NYSE: GBX), a leading supplier of railroad freight car equipment and services, today announced the appointment of T...
01-14 05:15
With U.S. stock futures trading slightly lower this morning on Friday, some of ...
01-09 19:06
Companies Reporting Before The Bell • Acuity (NYSE:AYI) is projected to report ...
01-08 19:11
The Greenbrier Companies, Inc. (NYSE:GBX) will release earnings results for the...
01-07 15:31
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从6美元升至8美元;HC Wainwright & Co.:维持MediWound"买入"评级,目标价从31美元升至36美元
2025-11-24 11:23
Goldman Sachs analyst Andrzej Tomczyk initiates coverage on Greenbrier Companies (NYSE:GBX) with a Sell rating and announces Price Target of $38.
2025-11-21 20:11
今日重点评级关注:HC Wainwright & Co.:维持Unicycive Therapeutics"买入"评级,目标价从9美元升至22美元;花旗:维持Arcus Biosciences"买入"评级,目标价从54美元升至56美元
2025-10-30 14:22